Manage Afatinib’s Adverse Events to Keep Patients on Treatment

Clinical trials are crucial to identifying adverse events associated with cancer therapies. But as treatments become more effective and extend survival, patients in the real world may be on a therapy much longer than it was tested in a clinical trial, especially in the case of targeted therapies. Toxicities and their management may differ when treatments become chronic.